{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:31:30Z","timestamp":1778081490616,"version":"3.51.4"},"reference-count":146,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.ijantimicag.2005.09.006","type":"journal-article","created":{"date-parts":[[2005,11,11]],"date-time":"2005-11-11T12:14:49Z","timestamp":1131711289000},"page":"427-441","source":"Crossref","is-referenced-by-count":29,"title":["Current state of three-dimensional characterisation of antifungal targets and its use for molecular modelling in drug design"],"prefix":"10.1016","volume":"26","author":[{"given":"E.","family":"Ruge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C.","family":"Korting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Borelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6 Suppl.","key":"10.1016\/j.ijantimicag.2005.09.006_bib1","first-page":"28S","article-title":"Structure-aided drug design: crystallography and computational approaches","volume":"36","author":"Ringe","year":"1995","journal-title":"J Nucl Med"},{"issue":"Suppl.","key":"10.1016\/j.ijantimicag.2005.09.006_bib2","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1017\/S0031182097008962","article-title":"A structure-based approach to drug discovery; crystallography and implications for the development of antiparasite drugs","volume":"114","author":"Hunter","year":"1997","journal-title":"Parasitology"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/1074-5521(94)90034-5","article-title":"Towards a pharmacological genetics","volume":"1","author":"Mitchison","year":"1994","journal-title":"Chem Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib4","first-page":"902","article-title":"Combinatorial chemistry","volume":"22","author":"Nielsen","year":"1994","journal-title":"Chem Ind"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1469-0691.2003.00489.x","article-title":"Microbial natural products as a source of antifungals","volume":"9","author":"Vicente","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0968-0896(01)00385-6","article-title":"Insights into the selective inhibition of Candida albicans secreted aspartyl protease: a docking analysis study","volume":"10","author":"Pranav Kumar","year":"2002","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib7","series-title":"Wirkstoffdesign","year":"1996"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1099-1352(199603)9:2<175::AID-JMR260>3.0.CO;2-D","article-title":"Molecular docking towards drug discovery","volume":"9","author":"Gschwend","year":"1996","journal-title":"J Mol Recognit"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib9","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1021\/jm00090a001","article-title":"3D database searching in drug design","volume":"35","author":"Martin","year":"1992","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/9780470125847.ch2","article-title":"Three-dimensional structure database searches","volume":"7","author":"Good","year":"1995","journal-title":"Rev Comp Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00125381","article-title":"Current methods for site-directed structure generation","volume":"8","author":"Lewis","year":"1994","journal-title":"J Comput Aided Mol Design"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/1568005033342145","article-title":"Strategy of computer-aided drug design","volume":"3","author":"Veselovsky","year":"2003","journal-title":"Curr Drug Targets Infect Disord"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-827X(01)01184-3","article-title":"Molecular modeling as a powerful technique for understanding small\u2013large molecules interactions","volume":"57","author":"Botta","year":"2002","journal-title":"Farmaco"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ps.614","article-title":"Ligand-based computer-aided pesticide design. A review of applications of the CoMFA and CoMSIA methodologies","volume":"59","author":"Bordas","year":"2003","journal-title":"Pest Manag Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2005.09.006_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1378\/chest.54.Supplement_1.296","article-title":"The discovery and development of amphotericin B","volume":"54","author":"Dutcher","year":"1968","journal-title":"Dis Chest"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib16","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1021\/ja00747a037","article-title":"Polyene macrolide antibiotic amphotericin B. Crystal structure of the N-iodoacetyl derivative","volume":"93","author":"Ganis","year":"1971","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0005-2736(74)90332-0","article-title":"Polyene antibiotic\u2013sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. III. Molecular structure of the polyene antibiotic\u2013cholesterol complexes","volume":"339","author":"de Kruijff","year":"1974","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/mol.52.4.560","article-title":"Molecular properties of amphotericin B membrane channel: a molecular dynamics simulation","volume":"52","author":"Baginski","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0005-2736(98)00134-5","article-title":"On the role of sterol in the formation of the amphotericin B channel","volume":"1375","author":"Cotero","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0005-2736(02)00581-3","article-title":"Comparative molecular dynamics simulations of amphotericin B\u2013cholesterol\/ergosterol membrane channels","volume":"1567","author":"Baginski","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/AAC.34.2.183","article-title":"Amphotericin B: current understanding of mechanisms of action","volume":"34","author":"Brajtburg","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0005-2736(94)90235-6","article-title":"Theoretical study of the complexation of amphotericin B with sterols","volume":"1191","author":"Langlet","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0005-2736(95)00169-7","article-title":"Theoretical study of the self-association of amphotericin B","volume":"1240","author":"Caillet","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0005-2736(76)90425-9","article-title":"Interaction of the polyene antibiotics with lipid bilayer vesicles containing cholesterol","volume":"426","author":"Gent","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0009-3084(96)02652-7","article-title":"The effect of aggregation state of amphotericin-B on its interactions with cholesterol- or ergosterol-containing phosphatidylcholine monolayers","volume":"85","author":"Barwicz","year":"1997","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0005-2736(98)00083-2","article-title":"The structuring effects of amphotericin B on pure and ergosterol- or cholesterol-containing dipalmitoylphosphatidylcholine bilayers: a differential scanning calorimetry study","volume":"1373","author":"Fournier","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0005-2736(01)00416-3","article-title":"Interactions of the drug amphotericin B with phospholipid membranes containing or not ergosterol: new insight into the role of ergosterol","volume":"1558","author":"Milhaud","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-3084(02)00071-3","article-title":"The effects of amphotericin B on pure and ergosterol- or cholesterol-containing dipalmitoylphosphatidylcholine bilayers as viewed by 2H NMR","volume":"119","author":"Paquet","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib29","first-page":"553","article-title":"Conformational analysis of amphotericin B molecule","volume":"10","author":"Silberstein","year":"1997","journal-title":"Membr Cell Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00254770","article-title":"Comparative conformational analysis of cholesterol and ergosterol by molecular mechanics","volume":"17","author":"Baginski","year":"1989","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0009-3084(02)00106-8","article-title":"Molecular modelling of membrane sterols with the use of the GROMOS 96 force field","volume":"120","author":"Baran","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0301-4622(01)00252-6","article-title":"Molecular modelling of amphotericin B\u2013ergosterol primary complex in water","volume":"95","author":"Baran","year":"2002","journal-title":"Biophys Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-2952(88)90168-2","article-title":"Quantitative structure\u2013activity relationships in amphotericin B derivatives","volume":"37","author":"Cheron","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.18388\/abp.2000_4069","article-title":"N-Methyl-N-d-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: monomer\/micelle control over selective toxicity","volume":"47","author":"Cybulska","year":"2000","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib35","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/AAC.31.11.1756","article-title":"Comparative in vitro and in vivo evaluation of N-d-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B","volume":"31","author":"Parmegiani","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2005.09.006_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1470-9465.2004.00841.x","article-title":"History of the development of azole derivatives","volume":"10","author":"Maertens","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib37","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/jm00194a023","article-title":"Antimycotic imidazoles. Part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent","volume":"22","author":"Heeres","year":"1979","journal-title":"J Med Chem"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2005.09.006_bib38","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.1093\/clinids\/12.Supplement_3.S267","article-title":"Discovery of fluconazole, a novel antifungal agent","volume":"12","author":"Richardson","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1368-5031.2004.0099.x","article-title":"Voriconazole for serious fungal infections","volume":"58","author":"Gothard","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib40","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1021\/jm990589g","article-title":"A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals","volume":"43","author":"Ji","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib41","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/jm020362c","article-title":"Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi","volume":"46","author":"Ji","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib42","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0006-2952(98)00096-3","article-title":"Influence of some novel N-substituted azoles and pyridines on rat hepatic CYP3A activity","volume":"55","author":"Slama","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0031-6865(97)00036-8","article-title":"Construction of a model of the Candida albicans lanosterol 14-alpha-demethylase active site using the homology modelling technique","volume":"72","author":"H\u00f6ltje","year":"1998","journal-title":"Pharm Acta Helv"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0022-2836(87)90190-2","article-title":"High-resolution crystal structure of cytochrome P450cam","volume":"195","author":"Poulos","year":"1987","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib45","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/0022-2836(94)90019-1","article-title":"Crystal structure and refinement of cytochrome P450terp at 2.3\u01fa resolution","volume":"236","author":"Hasemann","year":"1994","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nsb0295-144","article-title":"Structure of cytochrome P450eryF involved in erythromycin biosynthesis","volume":"2","author":"Cupp-Vickery","year":"1995","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib47","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.8342039","article-title":"Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's","volume":"261","author":"Ravichandran","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib48","first-page":"181","article-title":"Docking analysis of a series of cytochrome P-450(14) alpha DM inhibiting azole antifungals","volume":"15","author":"Talele","year":"1997","journal-title":"Drug Des Discov"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib49","doi-asserted-by":"crossref","unstructured":"Boscott PE, Grant GH. Modeling cytochrome P450 14 alpha demethylase (Candida albicans) from P450cam. J Mol Graph 1994;12:185\u201392, 195.","DOI":"10.1016\/0263-7855(94)80086-3"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib50","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0960-894X(98)00316-3","article-title":"Modeling, synthesis and biological activity of novel antifungal agents (1)","volume":"8","author":"Tsukuda","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0969-2126(01)00134-4","article-title":"Structure and function of cytochromes P450: a comparative analysis of three crystal structures","volume":"3","author":"Hasemann","year":"1995","journal-title":"Structure"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/14756369909030315","article-title":"Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: quantitative structure\u2013activity relationships (QSARs) within two related series of antifungal azole derivatives","volume":"14","author":"Lewis","year":"1999","journal-title":"J Enzyme Inhib"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib53","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.061562898","article-title":"Crystal structure of cytochrome P450 14alpha-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors","volume":"98","author":"Podust","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0162-0134(01)00388-9","article-title":"Substrate recognition sites in 14alpha-sterol demethylase from comparative analysis of amino acid sequences and X-ray structure of Mycobacterium tuberculosis CYP51","volume":"87","author":"Podust","year":"2001","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib55","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.48.2.568-574.2004","article-title":"Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding","volume":"48","author":"Xiao","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib56","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1128\/AAC.47.4.1213-1219.2003","article-title":"Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei","volume":"47","author":"Fukuoka","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2005.09.006_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/09546639009089021","article-title":"The early development of allylamine antimycotics","volume":"1","author":"Mieth","year":"1990","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib58","unstructured":"Leitner K-H, editor. Von der Idee zum Markt: Die 50 besten Innovationen \u00d6sterreichs. Erfolgsgeschichten der \u00f6sterreichischen Industrie zwischen 1975 und 2000. Wien: B\u00f6hlau Verlag; 2003."},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib59","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1021\/jm00071a011","article-title":"Synthesis and structure\u2013activity relationships of naphthalene-substituted derivatives of the allylamine antimycotic terbinafine","volume":"36","author":"Nussbaumer","year":"1993","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1021\/jm00105a011","article-title":"Synthesis and structure\u2013activity relationships of benzo[b]thienylallylamine antimycotics","volume":"34","author":"Nussbaumer","year":"1991","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib61","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1021\/jm00031a010","article-title":"Synthesis and structure\u2013activity relationships of the novel homopropargylamine antimycotics","volume":"37","author":"Nussbaumer","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib62","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/jm00010a029","article-title":"Synthesis and structure\u2013activity relationships of side-chain-substituted analogs of the allylamine antimycotic terbinafine lacking the central amino function","volume":"38","author":"Nussbaumer","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib63","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/AAC.40.2.443","article-title":"Characterisation of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents","volume":"40","author":"Favre","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 39","key":"10.1016\/j.ijantimicag.2005.09.006_bib64","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2133.1992.tb00001.x","article-title":"Terbinafine: mode of action and properties of the squalene epoxidase inhibition","volume":"126","author":"Ryder","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib65","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1021\/jm9806852","article-title":"Comparative molecular field analysis of fungal squalene epoxidase inhibitors","volume":"42","author":"Gokhale","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/abbi.1997.9908","article-title":"Differential inhibition of fungal and mammalian squalene epoxidases by the benzylamine SDZ SBA 586 in comparison with the allylamine terbinafine","volume":"340","author":"Favre","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib67","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/S0968-0896(00)00178-4","article-title":"Understanding the antifungal activity of terbinafine analogues using quantitative structure\u2013activity relationship (QSAR) models","volume":"8","author":"Gokhale","year":"2000","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.40.2.279","article-title":"Antifungal agents: chemotherapeutic targets and immunologic strategies","volume":"40","author":"Georgopapadakou","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib69","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00003495-199549010-00008","article-title":"Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections","volume":"49","author":"Haria","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib70","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1749-6632.1988.tb40406.x","article-title":"Mode of action of morpholine derivatives","volume":"544","author":"Polak","year":"1988","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib71","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF00351674","article-title":"Isolation of the ERG2 gene, encoding sterol delta 8 \u2192 delta 7 isomerase, from the rice blast fungus Magnaporthe grisea and its expression in the maize smut pathogen Ustilago maydis","volume":"25","author":"Keon","year":"1994","journal-title":"Curr Genet"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib72","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0378-1119(94)90728-5","article-title":"The identification of a gene family in the Saccharomyces cerevisiae ergosterol biosynthesis pathway","volume":"140","author":"Lai","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0378-1119(94)00902-5","article-title":"Cloning and sequence analysis of an ERG24 homolog from Schizosaccharomyces pombe","volume":"155","author":"Smith","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib74","series-title":"Ancotil flucytosin: status quo & perspektiven","year":"1999"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib75","series-title":"Lokale Pilzinfektionen","article-title":"Medikament\u00f6se Behandlung von lokalen Pilzinfektionen \u2014 Flucytosin","author":"Bracher","year":"2001"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib76","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1006\/jmbi.2001.5277","article-title":"The structure of Escherichia coli cytosine deaminase","volume":"315","author":"Ireton","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib77","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0969-2126(03)00153-9","article-title":"The 1.14\u00c5 crystal structure of yeast cytosine deaminase: evolution of nucleotide salvage enzymes and implications for genetic chemotherapy","volume":"11","author":"Ireton","year":"2003","journal-title":"Structure (Camb)"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib78","doi-asserted-by":"crossref","first-page":"19111","DOI":"10.1074\/jbc.M300874200","article-title":"Crystal structure of yeast cytosine deaminase. Insights into enzyme mechanism and evolution","volume":"278","author":"Ko","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib79","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1042\/bj0330240","article-title":"Griseofulvin, C17H17O6Cl, a metabolic product of Penicillium griseofulvum Dierks","volume":"33","author":"Oxford","year":"1939","journal-title":"Biochem J"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib80","first-page":"1317","article-title":"Griseofulvin","volume":"128","author":"Develoux","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib81","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-1110(88)90020-6","article-title":"Griseofulvin","volume":"195","author":"De Carli","year":"1988","journal-title":"Mutat Res"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib82","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0022-2836(76)90293-X","article-title":"Griseofulvin interacts with microtubules both in vivo and in vitro","volume":"102","author":"Weber","year":"1976","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib83","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0014-5793(76)80539-X","article-title":"Inhibition by griseofulvin of microtubule assembly in vitro","volume":"67","author":"Roobol","year":"1976","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib84","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0006-291X(81)80195-7","article-title":"Griseofulvin at low concentration inhibits the rate of microtubule polymerization in vitro","volume":"102","author":"Keates","year":"1981","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib85","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/0006-291X(82)91052-X","article-title":"Griseofulvin: association with tubulin and inhibition of in vitro microtubule assembly","volume":"105","author":"Sloboda","year":"1982","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib86","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1248\/bpb1978.7.156","article-title":"Viscometric and electron microscopic analysis of effects of griseofulvin and its derivatives on in vitro polymerization of microtubule proteins and depolymerization of microtubules","volume":"7","author":"Sato","year":"1984","journal-title":"J Pharmacobiodyn"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib87","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1248\/cpb.45.2011","article-title":"Syntheses and antifungal activity of dl-griseofulvin and its congeners. III","volume":"45","author":"Takeuchi","year":"1997","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib88","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ardp.19963290706","article-title":"Sulfogriseofulvin derivatives. Synthesis by [4+2]cycloaddition, structure, properties, crystal structure analysis, and antifungal activity of spiro[1,3-benzoxathiole-2,1\u2032-cyclohex-2\u2032-en]-4\u2032-one 3,3-dioxides","volume":"329","author":"Friedrich","year":"1996","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib89","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1128\/AAC.47.7.2273-2282.2003","article-title":"Molecular basis for fungal selectivity of novel antimitotic compounds","volume":"47","author":"Lila","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib90","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1006\/jmbi.2001.5077","article-title":"Refined structure of alpha beta-tubulin at 3.5\u00c5 resolution","volume":"313","author":"Lowe","year":"2001","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib91","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/AAC.48.5.1739-1748.2004","article-title":"Screening for microtubule-disrupting antifungal agents by using a mitotic-arrest mutant of Aspergillus nidulans and novel action of phenylalanine derivatives accompanying tubulin loss","volume":"48","author":"Kiso","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib92","first-page":"31","article-title":"New antifungal drug targets: a vision for the future","volume":"64","author":"Kurtz","year":"1998","journal-title":"ASM News"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib93","first-page":"228","article-title":"Antifungal drug targets: Candida secreted aspartyl protease and fungal wall beta-glucan synthesis","volume":"4","author":"Goldman","year":"1995","journal-title":"Infect Agents Dis"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib94","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/1568005014606107","article-title":"1,3-beta-Glucan synthase: a useful target for antifungal drugs","volume":"1","author":"Liu","year":"2001","journal-title":"Curr Drug Targets Infect Disord"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib95","doi-asserted-by":"crossref","first-page":"12907","DOI":"10.1073\/pnas.91.26.12907","article-title":"The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-d-glucan synthase","volume":"91","author":"Douglas","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib96","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1128\/MCB.15.10.5671","article-title":"Differential expression and function of two homologous subunits of yeast 1,3-beta-d-glucan synthase","volume":"15","author":"Mazur","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib97","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1128\/jb.178.15.4381-4391.1996","article-title":"Isolation of a gene involved in 1,3-beta-glucan synthesis in Aspergillus nidulans and purification of the corresponding protein","volume":"178","author":"Kelly","year":"1996","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib98","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","article-title":"Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-d-glucan synthase inhibitors","volume":"41","author":"Douglas","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib99","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/JB.181.2.444-453.1999","article-title":"A glucan synthase FKS1 homolog in Cryptococcus neoformans is single copy and encodes an essential function","volume":"181","author":"Thompson","year":"1999","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/(SICI)1097-0061(20000330)16:5<451::AID-YEA540>3.0.CO;2-O","article-title":"Molecular cloning and characterisation of a glucan synthase gene from the human pathogenic fungus Paracoccidioides brasiliensis","volume":"16","author":"Pereira","year":"2000","journal-title":"Yeast"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib101","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1128\/JB.183.7.2273-2279.2001","article-title":"Glucan synthase complex of Aspergillus fumigatus","volume":"183","author":"Beauvais","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib102","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00284-002-3884-5","article-title":"Neurospora crassa FKS protein binds to the (1,3)beta-glucan synthase substrate, UDP-glucose","volume":"46","author":"Schimoler-O\u2019Rourke","year":"2003","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib103","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1432-1033.1993.tb17885.x","article-title":"Predicting the topology of eukaryotic membrane proteins","volume":"213","author":"Sipos","year":"1993","journal-title":"Eur J Biochem"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2005.09.006_bib104","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/mmy.39.1.55.66","article-title":"Fungal beta(1,3)-d-glucan synthesis","volume":"39","author":"Douglas","year":"2001","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib105","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/hlca.19740570818","article-title":"Metabolites of microorganisms. 143. Echinocandin B, a novel polypeptide-antibiotic from Aspergillus nidulans var. echinulatus: isolation and structural components","volume":"57","author":"Nyfeler","year":"1974","journal-title":"Helv Chim Acta"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib106","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.44.2.368-377.2000","article-title":"Discovery of novel antifungal (1,3)-beta-d-glucan synthase inhibitors","volume":"44","author":"Onishi","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib107","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.mi.48.100194.002351","article-title":"Antibiotics that inhibit fungal cell wall development","volume":"48","author":"Debono","year":"1994","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib108","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.7164\/antibiotics.45.1886","article-title":"Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species","volume":"45","author":"Schmatz","year":"1992","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib109","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1128\/AAC.38.12.2750","article-title":"Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis","volume":"38","author":"Kurtz","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib110","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.39.6.1320","article-title":"New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat","volume":"39","author":"Schmatz","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib111","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0960-894X(00)00678-8","article-title":"Synthesis and antifungal activities of novel 1,3-beta-d-glucan synthase inhibitors. Part 1","volume":"11","author":"Masubuchi","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib112","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0960-894X(01)00178-0","article-title":"Synthesis and antifungal activities of novel 1,3-beta-d-glucan synthase inhibitors. Part 2","volume":"11","author":"Masubuchi","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib113","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal agents: mechanisms of action","volume":"11","author":"Odds","year":"2003","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib114","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0925-4439(02)00085-6","article-title":"From natural products to clinically useful antifungals","volume":"1587","author":"Barrett","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib115","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib118","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0723-2020(00)80062-4","article-title":"The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species, biological activity and taxonomy of the producing organisms","volume":"23","author":"Pelaez","year":"2000","journal-title":"Syst Appl Microbiol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib119","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/02681219780000961","article-title":"Lipopeptide inhibitors of fungal glucan synthase","volume":"35","author":"Kurtz","year":"1997","journal-title":"J Med Vet Mycol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/AAC.48.1.319-322.2004","article-title":"FKS1 mutations responsible for selective resistance of Saccharomyces cerevisiae to the novel 1,3-beta-glucan synthase inhibitor arborcandin C","volume":"48","author":"Ohyama","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib121","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1128\/jb.176.18.5686-5696.1994","article-title":"A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-d-glucan synthase","volume":"176","author":"Douglas","year":"1994","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib122","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1128\/AAC.42.10.2694","article-title":"Translation elongation factor 2 is part of the target for a new family of antifungals","volume":"42","author":"Capa","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib123","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1515\/bchm.1998.379.7.831","article-title":"Yeast elongation factor 3: structure and function","volume":"379","author":"Chakraburtty","year":"1998","journal-title":"Biol Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib124","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1074\/jbc.273.6.3148","article-title":"Elongation factor 2 as a novel target for selective inhibition of fungal protein synthesis","volume":"273","author":"Justice","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1359-6446(99)01430-0","article-title":"Emerging novel antifungal agents","volume":"5","author":"Fostel","year":"2000","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib126","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/j.1460-2075.1994.tb06675.x","article-title":"The crystal structure of elongation factor G complexed with GDP, at 2.7\u00c5 resolution","volume":"13","author":"Czworkowski","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib127","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1002\/j.1460-2075.1994.tb06676.x","article-title":"Three-dimensional structure of the ribosomal translocase: elongation factor G from Thermus thermophilus","volume":"13","author":"AEvarsson","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1107\/S090744490100052X","article-title":"Crystallographic phasing of myristoyl-CoA-protein N-myristoyltransferase using an iodinated analog of myristoyl-CoA","volume":"57","author":"Futterer","year":"2001","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib129","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1517\/13543784.11.8.1117","article-title":"Antifungals targeted to protein modification: focus on protein N-myristoyltransferase","volume":"11","author":"Georgopapadakou","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nsb0398-213","article-title":"Crystal structure of the anti-fungal target N-myristoyl transferase","volume":"5","author":"Weston","year":"1998","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib131","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1074-5521(02)00240-5","article-title":"Crystal structures of Candida albicans N-myristoyltransferase with two distinct inhibitors","volume":"9","author":"Sogabe","year":"2002","journal-title":"Chem Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib132","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0223-5234(00)01202-2","article-title":"A feature based pharmacophore for Candida albicans MyristoylCoA: protein N-myristoyltransferase inhibitors","volume":"36","author":"Karki","year":"2001","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib133","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0960-894X(01)00808-3","article-title":"Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 2","volume":"12","author":"Ebiike","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib134","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0960-894X(02)00844-2","article-title":"Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 3","volume":"13","author":"Kawasaki","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib135","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1016\/S0968-0896(03)00305-5","article-title":"3D-QSAR of N-myristoyltransferase inhibiting antifungal agents by CoMFA and CoMSIA methods","volume":"11","author":"Purushottamachar","year":"2003","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib136","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1099\/00221287-147-8-1997","article-title":"Candida albicans proteinases: resolving the mystery of a gene family","volume":"147","author":"Hube","year":"2001","journal-title":"Microbiology"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib137","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1128\/IAI.71.6.3227-3234.2003","article-title":"The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium","volume":"71","author":"Schaller","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib138","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1006\/jmbi.1993.1679","article-title":"Crystallization of inhibited aspartic proteinase from Candida albicans","volume":"234","author":"Cutfield","year":"1993","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib139","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2174\/0929867013372698","article-title":"Candida proteases and their inhibition: prospects for antifungal therapy","volume":"8","author":"Stewart","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib140","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0969-2126(01)00261-1","article-title":"The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors","volume":"3","author":"Cutfield","year":"1995","journal-title":"Structure"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib141","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/pro.5560050408","article-title":"Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents","volume":"5","author":"Abad-Zapatero","year":"1996","journal-title":"Protein Sci"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib142","doi-asserted-by":"crossref","first-page":"12700","DOI":"10.1021\/bi970613x","article-title":"High-resolution structure of the extracellular aspartic proteinase from Candida tropicalis yeast","volume":"36","author":"Symersky","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib143","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/prot.340110407","article-title":"Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons","volume":"11","author":"Nicholls","year":"1991","journal-title":"Proteins"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib144","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/MMBR.67.3.400-428.2003","article-title":"Candida albicans secreted aspartyl proteinases in virulence and pathogenesis","volume":"67","author":"Naglik","year":"2003","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib145","first-page":"319","article-title":"Inhibitors of aspartic proteases in human diseases: molecular modeling comes of age","volume":"54","author":"Hoegl","year":"1999","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib146","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-1-4615-5373-1_41","article-title":"Structure of secreted aspartic proteinases from Candida. Implications for the design of antifungal agents","volume":"436","author":"Abad-Zapatero","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib147","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0167-4838(00)00068-6","article-title":"Enzymic characteristics of secreted aspartic proteases of Candida albicans","volume":"1480","author":"Koelsch","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2005.09.006_bib148","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1046\/j.1432-1327.2001.02152.x","article-title":"Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors","volume":"268","author":"Pichova","year":"2001","journal-title":"Eur J Biochem"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905002633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905002633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T16:01:35Z","timestamp":1706716895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857905002633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":146,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0924857905002633"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.09.006","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}